Emcure Pharmaceuticals received the USFDA's Establishment Inspection Report (EIR) for its Sanand facility.

The inspection is closed with a 'Voluntary Action Indicated' (VAI) classification, signaling a positive regulatory outcome for the plant and no action required by the FDA.